TC BioPharm Files May 2025 6-K Report
Ticker: TCBWF · Form: 6-K · Filed: May 6, 2025 · CIK: 1872812
Sentiment: neutral
Topics: sec-filing, 6-k, regulatory-update
TL;DR
TC BioPharm filed its monthly 6-K, just standard SEC paperwork.
AI Summary
TC BioPharm (Holdings) plc filed a Form 6-K on May 6, 2025, reporting its activities for the month of May 2025. The company, incorporated in Scotland, United Kingdom, is involved in the biological products sector. This filing is made under the Securities Exchange Act of 1934.
Why It Matters
This filing provides an update on the company's regulatory reporting status and confirms its adherence to SEC requirements for foreign private issuers.
Risk Assessment
Risk Level: low — This filing is a routine administrative report and does not contain new financial or operational information that would typically indicate significant risk.
Key Players & Entities
- TC BioPharm (Holdings) plc (company) — Filer of the report
- 001-41231 (company) — SEC File Number
- 20250506 (date) — Filing date
FAQ
What is the primary business of TC BioPharm (Holdings) plc?
TC BioPharm (Holdings) plc is involved in the biological products sector, specifically classified under 'BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]'.
What form is TC BioPharm (Holdings) plc filing?
TC BioPharm (Holdings) plc is filing a Form 6-K, which is a Report of Foreign Private Issuer.
When was this Form 6-K filed?
This Form 6-K was filed on May 6, 2025.
Where is TC BioPharm (Holdings) plc based?
TC BioPharm (Holdings) plc is based in Holytown, Motherwell, Scotland, United Kingdom.
Does TC BioPharm (Holdings) plc file annual reports under Form 20-F?
Yes, the filing indicates that the registrant files or will file annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 6, 2025 regarding TC BioPharm (Holdings) plc (TCBWF).